A new era: artificial intelligence and machine learning in prostate cancer
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0193-3
Merging new-age biomarkers and nanodiagnostics for precision prostate cancer management
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0178-2
Molecular and histopathology directed therapy for advanced bladder cancer
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0208-0
Long non-coding RNAs in genitourinary malignancies: a whole new world
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0195-1
The influence of BRCA2 mutation on localized prostate cancer
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0164-8
Technologies for image-guided surgery for managing lymphatic metastases in prostate cancer
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-018-0140-8
Harnessing the mesenchymal stem cell secretome for regenerative urology
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0169-3
Enzalutamide, apalutamide, or darolutamide: are apples or bananas best for patients?
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0186-2
Optimizing pharmacokinetics of intravesical chemotherapy for bladder cancer
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0220-4
Landmarks in vaginal mesh development: polypropylene mesh for treatment of SUI and POP
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0230-2
Ambulatory urodynamic monitoring: state of the art and future directions
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0175-5
Prostate cancer in sexual minorities and the influence of HIV status
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0194-2
Organ preservation in bladder cancer: an opportunity for truly personalized treatment
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0199-x
New approaches for effective and safe pelvic radiotherapy in high-risk prostate cancer
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0213-3
Video review for measuring and improving skill in urological surgery
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-018-0138-2
Physical activity as an adjunct treatment for erectile dysfunction
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0210-6
IBD as a risk factor for prostate cancer: what is the link?
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0157-7
Urogenital tuberculosis — epidemiology, pathogenesis and clinical features
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0228-9
First point-of-care PSA test for prostate cancer detection
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0179-1
Targeting DLL3 in neuroendocrine prostate cancer
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0190-6
Health technology assessment methodology in metastatic renal cell carcinoma
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0257-4
Clinical decision-making with AR-V7
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0259-2
AR variants: lost in translation to clinical practice?
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0204-4
18F-fluciclovine PET or PSMA PET for prostate cancer imaging?
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0255-6
Prostate cancer: a tale of two sides
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0152-z
The Urology Care Foundation — trusted online resources in an era of misinformation
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0215-1
Testosterone in women: are we closing the gender gap?
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0266-3
Neisseria gonorrhoeae resistance driven by antibiotic use
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0206-2
2019 ASCO Genitourinary Cancers Symposium
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0168-4
Combining options in metastatic prostate cancer
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0217-z
Hyperpolarized MRI illustrates metabolic response to therapy
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-018-0139-1
Improving care to decrease stone recurrence and opioid use
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0275-2
Atezolizumab in understudied populations with bladder cancer
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0200-8
To see or not to see — what renders prostate cancer visible?
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0167-5
Budding prognostic technique for muscle-invasive bladder cancer
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0187-1
Evolutionary and clinical trajectories of early-onset prostate cancer
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0144-z
Barcelona! What a beautiful (therapeutic) horizon
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0177-3
Continence in nursing homes: a state of irreversible decline?
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0172-8
AVPR1A: a target in CRPC?
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0218-y
Emerging role for the unfolded protein response
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0156-8
First total penis, scrotum and abdominal wall transplant
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0265-4
Challenging beliefs of testosterone therapy and prostate cancer
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0253-8
A new class of AR antagonists?
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0147-9
Understanding clinical variables to improve empirical antibiotic therapy for UTI
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0240-0
Steaming ahead with BPH therapy
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0159-5
AR activity in treatment-naive prostate tumours
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0244-9
Genomic correlates of clinical outcomes
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0201-7
PSMA ADC shows promise in advanced disease
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0161-y
The perfect PARTNER: no HIV transmission with ART
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0205-3
Understanding obesity interactions with germ cell tumours
来源期刊:Nature Reviews UrologyDOI:10.1038/s41585-019-0202-6